S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Concord Medical Signs Consulting Agreement with MD Anderson Cancer Center|
|Celator(R) Pharmaceuticals Announces Start of Clinical Study of CPX-351 in Relapsed/Refractory Higher Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients|
|Sunesis Announces MD Anderson Sponsored Trial of Vosaroxin in AML and High-Risk MDS Poster to be Presented at AACR 2014|
|Galectin Therapeutics Announces First Patient Dosed in Second Cohort of Phase 1 Trial of GR-MD-02 for NASH With Advanced Fibrosis|
|Sunesis Announces MD Anderson Sponsored Study of Vosaroxin in AML and High-Risk MDS Poster to be Presented at ASCO 2014|
|Galectin Therapeutics Completes Enrollment of Second Cohort of Phase 1 Trial of GR-MD-02 for NASH (Fatty Liver Disease) With Advanced Fibrosis|
|Onconova Therapeutics, Inc. Reports First Quarter 2014 Financial and Operational Results|
|Hemp, Inc. Subsidiary, Industrial Hemp and Medical Marijuana Consulting Company, Inc., Signs Consulting Services Agreement With Cloud Medical Doctor Software Corporation|
|Trovagene Announces Data Presentations, Published Abstracts at Annual Meeting of American Society of Clinical Oncology|
|Galectin Therapeutics to Announce Results From First Cohort of Phase 1 Clinical Trial in Fatty Liver Disease|
Click above to view more mutual fund data and stats for md - Midland Exploration Inc.